NasdaqGS - Nasdaq Real Time Price
USD
BioCryst Pharmaceuticals, Inc. (BCRX)
8.46
+0.09
(+1.08%)
As of 12:53:10 PM EDT. Market Open.
Trade BCRX on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutBioCryst is highlighting new clinical and real-world data for ORLADEYO and investigational navenibart at the 2026 ACAAI meeting. The company also secured U.S. approval for a 150-milligram ORLADEYO oral-pellet formulation, while attention now turns to the November 4 earnings report and growing competition in hereditary angioedema treatments.
